Recurrent Malignant Testicular Germ Cell Tumor Completed Phase Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028803 (Recurrent Malignant Testicular Germ Cell Tumor)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs